mRNA delivery through fibronectin associated liposome-apatite particles: a new approach for enhanced mRNA transfection to mammalian cell.

It was believed for a long time that mRNA is very unstable, and can not be used for therapeutic purposes. In the last decade, however, many research groups proved its transfection feasibility along with advantages and applications. Our investigation is aimed at establishing a potent and efficient mRNA delivery system. We previously reported that an inorganic-organic hybrid carrier by exploiting the advantages of inorganic nano apatite particles onto organic carrier DOTAP {N-[1-(2,3-dioleoloxy)propyl]-N,N,N-trimethyl ammonium chloride} and showed potential effect of carbonate apatite particles on each of the mRNA delivery steps in dividing and non-dividing cell. Here, we report on the development of a more efficient mRNA carrier by complexing ECM protein, fibronectin with the DOTAP-apatite carrier. The carrier showed enhanced uptake of luciferase mRNA both qualitatively and quantitatively. Accelerated cellular endocytosis rate was evaluated using labeled endosome. Finally expression of lucifearse mRNA was higher for fibronectin complexed carrier in compared to the uncoated one.

[1]  N. Bavarsad,et al.  mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[2]  J. Hecker,et al.  Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells. , 2010, International journal of pharmaceutics.

[3]  F. Zohra,et al.  High performance mRNA transfection through carbonate apatite-cationic liposome conjugates. , 2009, Biomaterials.

[4]  H. Rammensee,et al.  Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients , 2009, Journal of immunotherapy.

[5]  F. Zohra,et al.  Effective delivery with enhanced translational activity synergistically accelerates mRNA-based transfection. , 2007, Biochemical and biophysical research communications.

[6]  W. Ge,et al.  Truncated TERT mRNA transfected dendritic cells evoke TERT specific antitumor response in vivo. , 2007, Hepato-gastroenterology.

[7]  G. Gaudernack,et al.  Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells , 2006, Cancer Immunology, Immunotherapy.

[8]  Wen-Chao Liu,et al.  Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells. , 2006, Cellular immunology.

[9]  F. Zohra,et al.  Drastic effect of nanoapatite particles on liposome-mediated mRNA delivery to mammalian cells. , 2005, Analytical biochemistry.

[10]  F. Zohra,et al.  Integrin-supported fast rate intracellular delivery of plasmid DNA by extracellular matrix protein embedded calcium phosphate complexes. , 2005, Biochemistry.

[11]  S. Aamdal,et al.  Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination , 2005, Cancer Gene Therapy.

[12]  V. Vogel,et al.  Fibronectin conformational changes induced by adsorption to liposomes. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Andrés J. García,et al.  α2β1 integrin‐specific collagen‐mimetic surfaces supporting osteoblastic differentiation , 2004 .

[14]  W. Driessen,et al.  Peptide-mediated Gene Transfer of Cationic Lipid/Plasmid DNA Complexes to Endothelial Cells , 2004, Journal of drug targeting.

[15]  Chi-Hung Lin,et al.  Studies on the microspheres comprised of reconstituted collagen and hydroxyapatite. , 2004, Biomaterials.

[16]  R. Schiffelers,et al.  Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. , 2004, Nucleic acids research.

[17]  T. Kissel,et al.  Integrin targeting using RGD‐PEI conjugates for in vitro gene transfer , 2003, The journal of gene medicine.

[18]  D. Willis,et al.  Formation of LID vector complexes in water alters physicochemical properties and enhances pulmonary gene expression in vivo , 2003, Gene Therapy.

[19]  J. Hecker,et al.  Stability of mRNA/cationic lipid lipoplexes in human and rat cerebrospinal fluid: methods and evidence for nonviral mRNA gene delivery to the central nervous system. , 2003, Human gene therapy.

[20]  Y. Shinohara,et al.  Lipoplex size determines lipofection efficiency with or without serum , 2003, Molecular membrane biology.

[21]  P. Harvie,et al.  Targeting of Lipid-Protamine-DNA (LPD) Lipopolyplexes Using RGD Motifs , 2003, Journal of liposome research.

[22]  M. Ogris,et al.  Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells. , 2001, Nucleic acids research.

[23]  J. Hecker,et al.  Nonviral gene delivery to the lateral ventricles in rat brain: initial evidence for widespread distribution and expression in the central nervous system. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  S. Nair,et al.  RNA transfected dendritic cells as cancer vaccines. , 2000, Current opinion in molecular therapeutics.

[25]  Seng H. Cheng,et al.  Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  M. Cotten,et al.  Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus , 2000, Gene Therapy.

[27]  K. Karikó,et al.  Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA , 1999, Gene Therapy.

[28]  M. Goligorsky,et al.  RGD‐recognizing integrins mediate interactions of human prostate carcinoma cells with endothelial cells in vitro , 1999, The Prostate.

[29]  M. Stedman,et al.  Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes. , 1999, Human gene therapy.

[30]  D. Escande,et al.  Polyethylenimine but Not Cationic Lipids Promotes Transgene Delivery to the Nucleus in Mammalian Cells* , 1998, The Journal of Biological Chemistry.

[31]  R. Levinsky,et al.  Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector. , 1998, Human gene therapy.

[32]  D. Scherman,et al.  Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes. , 1998, Biochimica et biophysica acta.

[33]  M. Somerman,et al.  Expression of Adhesion Molecules during Tooth Resorption in Feline Teeth: A Model System for Aggressive Osteoclastic Activity , 1996, Journal of dental research.

[34]  R. Klebe,et al.  Comments on the Clinical Application of Fibronectin in Dentistry , 1988, Journal of dental research.

[35]  K. Takita,et al.  Immunofluorescence localization of type I and type III collagen and fibronectin in mouse dental tissues in late development and during molar eruption. , 1987, Archives of oral biology.